Following each of their biannual meetings, both the ICH Assembly and the ICH MedDRA Management Board issue press releases to inform stakeholders on decisions taken during their meetings. On occasion, press releases are also issued between meetings.

In addition to being published on the ICH website, press releases are also distributed through ICH’s press network. If your journal or newspaper would like to receive ICH press releases please contact the ICH Secretariat.

4 June 2012

MedDRA Management Board, Fukuoka, Japan, 2-3 June 2012

The MSSO provided data on user uptake of the new MedDRA Version Analysis Tool (MVAT). MVAT assists users in understanding the differences between any two versions of MedDRA...

10 November 2011

ICH Steering Committee, Seville, Spain, 9-10 November 2011

Following an extended consultation period, the SC approved a revised ICH S2(R1) Guideline for genotoxicity testing and data interpretation for medicines intended for human use.

6 November 2011

MedDRA Management Board, Seville, Spain, 5-6 November 2011

The MedDRA Management Board is pleased to announce that the 2012 MSSO MedDRA subscription fees will remain the same as 2011.

18 June 2011

ICH Steering Committee, Cincinnati, OH, US, 15-16 June 2011

For the first time, non-ICH regulators have been nominated to serve as experts in some quality, safety and efficacy expert working groups (EWGs). ICH welcomed the active participation of technical experts from China, Chinese...